Skip to main content
Behavioral Healthcare Executive
Abuse, PTSD & Trauma
Alzheimer’s Disease, Dementia & Cognitive Disorders
Child & Adolescent Psychiatry
Major Depressive Disorder
Psych Congress Year-Round
Schizophrenia & Psychotic Disorders
Your Questions Answered
Cocaine, Meth & Stimulant Summit
Elevate by Psych Congress
Evolution of Psychotherapy
Lunch and Learn Series
The Midwest Opioid Summit: An NCAD Meeting
National Conference on Addiction Disorders East
National Conference on Addiction Disorders West
Psych Congress Regionals
Rx Drug Abuse & Heroin Summit
Treatment Center Investment & Valuation Retreat
Insights from the APA Annual Meeting
Psych Congress On-Demand
NCAD East On-Demand
Centers of Excellence
Advertising And Event Opportunities
Editorial Advisory Board
Detecting Mixed Features in Major Depression
December 05, 2019
W. Clay Jackson, MD, DipTh, explains the difference between major depressive disorder and major depressive disorder with mixed features.
Best Practices for Administering Esketamine
November 07, 2019
Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."
Q&A With Phillip J. Resnick on School Shootings
November 01, 2019
In this video, forensic psychiatrist Phillip J. Resnick, MD discusses common traits in school shooters, misconceptions people have about school shooters, and how mental health clinicians can help…
Using Thyroid Hormone in Depression Treatment
October 28, 2019
Michael Thase, MD, discusses when clinicians should consider using thyroid hormone as an antidepressant augmentation strategy and possible risks of the approach.
Marijuana in the 21st Century
October 28, 2019
Ben Cort, CEO of Foundry Treatment Center Steamboat Springs in Colorado, discusses the importance of avoiding microaggressions when working with cannabis-dependent patients, as well as the…
Addressing the Challenges of Providing MAT to Pregnant and Nursing Women
October 28, 2019
D. Tyler Coyle, MD, MS, of the University School of Medicine – Addiction Research and Treatment Services, dispels misconceptions around the safety of medications such as buprenorphine and methadone…
Treating ADHD in Patients With Hypertension or Cardiovascular Disease
September 11, 2019
Anthony L. Rostain, MD, MA, discusses steps to take when treating attention-deficit/hyperactivity disorder (ADHD) in patients with hypertension or cardiovascular disease.
Combining Stimulants and Nonstimulants in ADHD Treatment
September 05, 2019
Anthony L. Rostain, MD, MA, discusses factors to consider when combining stimulants and nonstimulants in the treatment of attention-deficit/hyperactivity disorder (ADHD).
NCAD | Celebrating 10 Years as the Leader in Addiction Education
September 04, 2019
For the past 10 years, the National Conference on Addiction Disorders has provided professionals with the tools they need to address unprecedented changes in the field of addiction.
Should You Start ADHD Treatment With a Stimulant or Nonstimulant?
August 26, 2019
When a patient is newly diagnosed with attention-deficit/hyperactivity disorder (ADHD), is it better to begin treatment with a stimulant or a nonstimulant? Anthony L. Rostain, MD, MA, shares his…
Back to Top